19.90
-0.10
(-0.50%)
At close: January 28 at 8:12:03 AM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in JPY | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 5 | 1 | 13 | 13 |
Avg. Estimate | 290.33B | 254B | 1.16T | 1.18T |
Low Estimate | 283.6B | 254B | 1.15T | 1.14T |
High Estimate | 295.1B | 254B | 1.17T | 1.21T |
Year Ago Sales | 273.81B | 236.9B | 1.11T | 1.16T |
Sales Growth (year/est) | 6.03% | 7.22% | 4.77% | 1.57% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
CUP0.MU | -- | -- | -- | -- |
S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Related Tickers
002422.SZ Sichuan Kelun Pharmaceutical Co., Ltd.
28.13
-0.04%
ON4.F Ono Pharmaceutical Co., Ltd.
10.20
+3.03%
CVGU.F CSPC Pharmaceutical Group Limited
2.0000
+0.50%
600436.SS PIENTZEHUANG
202.51
+0.75%
4536.T Santen Pharmaceutical Co., Ltd.
1,563.00
-0.19%
4151.T Kyowa Kirin Co., Ltd.
2,325.00
-0.15%
4578.T Otsuka Holdings Co., Ltd.
8,101.00
-0.16%
600276.SS HENGRUI PHARMA
44.65
+0.02%
4568.T Daiichi Sankyo Company, Limited
4,412.00
-0.90%
ALPMY Astellas Pharma Inc.
9.87
+1.33%